Hasil Pencarian - Woo P

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret<sup>®</sup>) in systemic juvenile idiopathic arthritis

    Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret<sup>®</sup>) in systemic juvenile idiopathic arthritis oleh Livermore P, Woo P

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre

    Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre oleh Livermore P, Woodworth T, Woo P

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept

    An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept oleh Livermore P, Woo P, Wedderburn LR

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment

    Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment oleh Ogilvie EM, Samuel JM, Woo P

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)

    Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with meth... oleh Hirani SP, Kassoumeri L, Mulligan K, Ruperto N, Woo P, Wedderburn LR, Newman SP

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

    Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA) oleh Hirani SP, Kassoumeri L, Etheridge A, Mulligan K, Ruperto N, Woo P, Wedderburn L, Newman SP

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)

    2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... oleh Ruperto N, Quartier P, Wulffraat N, Woo P, Loy A, Mouy R, Bader-Meunier B, Prakken B, Noseda E, Rordorf C

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey

    Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey oleh Gattorno M, Frenkel J, Ozen S, De Benedetti F, Konè-Paut I, Neven N, Girschick H, Özdogan H, Wouters C, Woo P, Hofer M, Dolezalova P, Toplak N, Richard V, Martini A, Ruperto N

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

    2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatme... oleh Ruperto N, Lovell DJ, Cuttica R, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Davidson J, Foeldvari I, Imundo L, Simonini G, Oppermann J, Shen YK, Visvanathan S, Fasanmade A, Mendelsohn A, Martini A, Giannini EH

    Diterbitkan 2008-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data

    Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data oleh Espada G, Pardeo M, Chaitow J, Brown D, Allen R, Zulian F, Zuber Z, Wulffraat N, Joos R, Dolezalova P, Burgos-Vargas R, Woo P, Schneider R, Ruperto N, Brunner H, De Benedetti F, Flato B, Gerloni V, Horneff G, Wright S, Kenwright A, Lovell D, Martini A

    Diterbitkan 2011-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment

    The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment oleh Touitou I, Woo P, Lachmann H, Dolezalova P, Rose C, Hentgen V, Wouters C, Vesely R, Stojanov S, Simon A, Arostegui J, Kummerle-Deschner J, Ozdogan H, Neven B, Girschick H, Kone-Paut I, Hofer M, De Benedetti F, Ozen S, Frenkel J, Toplak N, Martini A, Ruperto N, Gattorno M

    Diterbitkan 2011-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: